Florent Gros - Chairman & Founder @ Amyl Therapeutics

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Florent Gros is the Chairman & Founder at Amyl Therapeutics. He attended University of Mulhouse.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	GEMMABio	Earlybird Venture Capital	Yes	Seed Round - GEMMABio	obfuscated obfuscation
obfuscated obfuscation	ImCheck Therapeutics	Earlybird Venture Capital	Yes	Series C - ImCheck Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Oculis	Novartis Venture Fund	—	Series C - Oculis	obfuscated obfuscation
obfuscated obfuscation	Anokion	Novartis Venture Fund	—	Series B - Anokion	obfuscated obfuscation
obfuscated obfuscation	Oculis	Novartis Venture Fund	Yes	Series B - Oculis	obfuscated obfuscation
obfuscated obfuscation	Binx Health	Novartis Venture Fund	No	Series D - Binx Health	obfuscated obfuscation
obfuscated obfuscation	Myopowers Medical Technologies	Novartis Venture Fund	—	Series C - Myopowers Medical Technologies	obfuscated obfuscation
obfuscated obfuscation	Merus	Novartis Venture Fund	No	Series C - Merus	obfuscated obfuscation
obfuscated obfuscation	Binx Health	Novartis Venture Fund	No	Series C - Binx Health	obfuscated obfuscation
obfuscated obfuscation	Anokion	Novartis Venture Fund	Yes	Series A - Anokion	obfuscated obfuscation

Number of Current Jobs

has

current jobs including

Chairman & Founder

CEO & Founder

, and

Managing Director

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

holds

board and advisor roles including

Board Member

Board Member

, and

Board & Managing Director

Organization Name	Title At Company	Start Date	End Date
Immune System Therapeutics	Board Member	—	—
Myopowers Medical Technologies	Board Member	—	—
Binx Health	Board Member	—	—
Immune Targeting Systems	Board Member	—	—
Opsona	Board Member	—	—
Merus	Board Member	—	—

Hub Name	CB Rank (Hub)
Life Science Companies With Fewer Than 10 Employees	13,853
Europe, Middle East, and Africa (EMEA) Early Stage Companies With More Than $50M in Revenue	45,194
Belgium Companies With Fewer Than 100 Employees (Top 10K)	9,752
Life Science Early Stage Companies With Fewer Than 1000 Employees	40,163
Belgium Early Stage Companies	82,064
Belgium Biotechnology Companies	40,048
Belgium Companies With Less Than $500M in Revenue (Top 10K)	12,426
Belgium Medical Companies	58,052
Biotechnology Early Stage Companies With More Than $50M in Revenue	100,390
Europe, Middle East, and Africa (EMEA) Early Stage Companies With Fewer Than 10 Employees	101,697